These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 18447644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Caspase inhibitor ZVAD-fmk facilitates engraftment of donor hematopoietic stem cells in intra-bone marrow-bone marrow transplantation.
    Imai Y, Adachi Y, Shi M, Shima C, Yanai S, Okigaki M, Yamashima T, Kaneko K, Ikehara S.
    Stem Cells Dev; 2010 Apr; 19(4):461-8. PubMed ID: 19686047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Administration of granulocyte colony-stimulating factor to recipients followed by intra-bone marrow-bone marrow transplantation accelerates acceptance of allogeneic bone marrow cells in mice.
    Suzuki Y, Adachi Y, Zhang Y, Minamino K, Iwasaki M, Mukaide H, Shi M, Nakano K, Koike Y, Wang J, Koike-Kiriyama N, Shigematsu A, Yanai S, Ikehara S.
    Immunobiology; 2008 Apr; 213(5):427-35. PubMed ID: 18472051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes.
    Li Q, Hisha H, Yasumizu R, Fan TX, Yang GX, Li Q, Cui YZ, Wang XL, Song CY, Okazaki S, Mizokami T, Cui WH, Guo K, Li M, Feng W, Katou J, Ikehara S.
    Stem Cells; 2007 May; 25(5):1186-94. PubMed ID: 17322105
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM, Jones M, Levy RB.
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells.
    Miyake T, Inaba M, Fukui J, Ueda Y, Hosaka N, Kamiyama Y, Ikehara S.
    Clin Exp Immunol; 2008 Apr; 152(1):153-62. PubMed ID: 18307515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y, Adachi Y, Minamino K, Zhang Y, Iwasaki M, Nakano K, Koike Y, Ikehara S.
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
    Kushida T, Inaba M, Hisha H, Ichioka N, Esumi T, Ogawa R, Iida H, Ikehara S.
    Blood; 2001 May 15; 97(10):3292-9. PubMed ID: 11342461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.